To investigate the effect of MI-63 on paediatric sarcomas, specifically RMS, and the reactivation of p53 cell signalling, we designed an in vitro study examining cancer cell proliferation and presence of apoptosis after exposure to the inhibitor. Here, TP53 is linked to cancer.